Annual ROE
-88.43%
-26.33%-42.40%
December 31, 2023
Summary
- As of February 7, 2025, ADVM annual return on equity is -88.43%, with the most recent change of -26.33% (-42.40%) on December 31, 2023.
- During the last 3 years, ADVM annual ROE has fallen by -49.86% (-129.27%).
- ADVM annual ROE is now -103.65% below its all-time high of 2420.18%, reached on December 31, 2013.
Performance
ADVM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-69.14%
+5.65%+7.55%
September 30, 2024
Summary
- As of February 7, 2025, ADVM quarterly return on equity is -69.14%, with the most recent change of +5.65% (+7.55%) on September 30, 2024.
- Over the past year, ADVM quarterly ROE has increased by +11.60% (+14.37%).
- ADVM quarterly ROE is now -102.86% below its all-time high of 2420.18%, reached on December 31, 2013.
Performance
ADVM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ADVM ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.4% | +14.4% |
| 3 y3 years | -129.3% | -55.1% |
| 5 y5 years | -134.5% | -91.4% |
ADVM ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -128.0% | at low | -79.6% | +22.5% |
| 5 y | 5-year | -157.9% | at low | -113.6% | +22.5% |
| alltime | all time | -103.7% | at low | -102.9% | +22.5% |
Adverum Biotechnologies ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -69.14%(-7.6%) |
| Jun 2024 | - | -74.79%(-12.9%) |
| Mar 2024 | - | -85.87%(-3.8%) |
| Dec 2023 | -88.43%(+42.4%) | -89.22%(+10.5%) |
| Sep 2023 | - | -80.74%(+11.7%) |
| Jun 2023 | - | -72.29%(+6.7%) |
| Mar 2023 | - | -67.78%(+8.2%) |
| Dec 2022 | -62.10%(+60.1%) | -62.66%(+12.1%) |
| Sep 2022 | - | -55.88%(+13.5%) |
| Jun 2022 | - | -49.23%(+10.5%) |
| Mar 2022 | - | -44.57%(+15.8%) |
| Dec 2021 | -38.78%(+0.5%) | -38.49%(+5.5%) |
| Sep 2021 | - | -36.48%(+4.3%) |
| Jun 2021 | - | -34.97%(+8.0%) |
| Mar 2021 | - | -32.37%(-8.5%) |
| Dec 2020 | -38.57%(+12.5%) | -35.38%(-0.4%) |
| Sep 2020 | - | -35.53%(-10.0%) |
| Jun 2020 | - | -39.49%(+9.3%) |
| Mar 2020 | - | -36.13%(+1.5%) |
| Dec 2019 | -34.29% | -35.58%(+10.1%) |
| Sep 2019 | - | -32.33%(-0.6%) |
| Jun 2019 | - | -32.51%(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -32.24%(-4.1%) |
| Dec 2018 | -37.71%(+34.2%) | -33.62%(-0.7%) |
| Sep 2018 | - | -33.85%(+8.6%) |
| Jun 2018 | - | -31.17%(+9.4%) |
| Mar 2018 | - | -28.49%(-1.1%) |
| Dec 2017 | -28.10%(-42.2%) | -28.82%(-7.2%) |
| Sep 2017 | - | -31.06%(+5.7%) |
| Jun 2017 | - | -29.38%(-41.3%) |
| Mar 2017 | - | -50.09%(+5.1%) |
| Dec 2016 | -48.59%(+105.9%) | -47.65%(+12.1%) |
| Sep 2016 | - | -42.51%(+3.0%) |
| Jun 2016 | - | -41.27%(+102.2%) |
| Mar 2016 | - | -20.41%(+4.5%) |
| Dec 2015 | -23.60%(-30.7%) | -19.53%(-0.2%) |
| Sep 2015 | - | -19.57%(-7.3%) |
| Jun 2015 | - | -21.10%(-14.0%) |
| Mar 2015 | - | -24.53%(-23.2%) |
| Dec 2014 | -34.04%(-101.4%) | -31.92%(+6.0%) |
| Sep 2014 | - | -30.11%(-17.4%) |
| Jun 2014 | - | -36.44%(+31.4%) |
| Mar 2014 | - | -27.73%(-101.1%) |
| Dec 2013 | 2420.18%(+1232.4%) | 2420.18% |
| Dec 2012 | 181.64% | - |
FAQ
- What is Adverum Biotechnologies annual return on equity?
- What is the all time high annual ROE for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual ROE year-on-year change?
- What is Adverum Biotechnologies quarterly return on equity?
- What is the all time high quarterly ROE for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly ROE year-on-year change?
What is Adverum Biotechnologies annual return on equity?
The current annual ROE of ADVM is -88.43%
What is the all time high annual ROE for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual return on equity is 2420.18%
What is Adverum Biotechnologies annual ROE year-on-year change?
Over the past year, ADVM annual return on equity has changed by -26.33% (-42.40%)
What is Adverum Biotechnologies quarterly return on equity?
The current quarterly ROE of ADVM is -69.14%
What is the all time high quarterly ROE for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly return on equity is 2420.18%
What is Adverum Biotechnologies quarterly ROE year-on-year change?
Over the past year, ADVM quarterly return on equity has changed by +11.60% (+14.37%)